Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

The Role of Bisphosphonates in Osteoporosis Therapy Today

What is it about bisphosphonates as a class that makes them so efficacious—and what are some of the pitfalls?
  • Sponsored by

  • Overview

    Bisphosphonates were the first class of drugs to be approved for the treatment of osteoporosis, and they remain the foundation of treatment to this day. What is it about this class that makes it so efficacious—and what are some of the pitfalls? Host Dr. John Russell welcomes Sol Epstein, MD, FRCP, FACP, professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the University of Pennsylvania. Dr. Epstein is currently a paid consultant to Mission Pharmacal Company.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.